marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-14-2023
Adamis Pharmaceuticals Corporation Financial Ratios 2011-2024 | ADMP
Annual Financial Ratios Adamis Pharmaceuticals Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.7 | -1.9 | -1.2 | -1.2 | -3.1 | -4.1 | -2.8 | -4.6 | -4.9 | -6.9 | -11.8 | -2.1 |
P/S |
3.8 | 39.2 | 3.7 | 1.6 | 8.0 | 7.9 | 8.4 | - | - | - | - | - |
EPS |
-0.2 | -0.3 | -0.6 | -0.5 | -1 | -0.9 | -1.2 | -1.0 | -1.0 | -1.2 | -0.1 | -0.1 |
EV (Enterprise Value) |
28.5 M | 75.7 M | 81.8 M | 38.7 M | 113 M | 98 M | 62.7 M | 61.7 M | 39 M | 54.5 M | 61 M | 16.5 M |
EBITDA per Share |
-0.16 | -0.21 | -0.631 | -0.49 | -0.93 | -0.763 | -1.3 | -0.969 | -0.558 | -0.549 | -0.916 | -1.66 |
EV/EBITDA |
0.4 | -1.6 | -1.1 | -2.9 | -4.2 | -2.5 | -4.6 | -8.5 | -15.8 | -12.1 | -2.4 | |
PEG |
0.04 | 0.09 | 0.02 | -0.03 | 0.28 | -0.17 | 0.17 | 0.3 | -0.73 | 0.42 | 2.13 | -0.04 |
P/B |
-27.6 | 3.3 | 17.5 | 1.0 | 2.6 | 2.6 | 2.1 | 6.8 | 3.3 | -11.5 | -21.4 | -10.6 |
P/CF |
-0.7 | -2.3 | -2.8 | -1.6 | -3.3 | -6.0 | -2.5 | -6.1 | -2.4 | -19.5 | -17.4 | -3.4 |
ROE % |
3276.74 | -177.06 | -1412.17 | -81.32 | -83.54 | -64.58 | -76.89 | -145.72 | -66.92 | 166.24 | 180.47 | 505.91 |
ROA % |
-242.23 | -119.66 | -160.01 | -61.26 | -66.84 | -49.68 | -51.44 | -112.52 | -53.94 | -2050.21 | -2907.79 | -402.62 |
ROCE % |
3101.10 | -123.90 | -340.24 | -77.14 | -84.29 | -57.94 | -86.39 | -148.70 | -36.06 | 74.34 | 176.79 | 452.36 |
Current Ratio |
0.9 | 3.1 | 0.6 | 1.4 | 2.2 | 2.4 | 0.8 | 1.5 | 1.8 | 0.1 | 0.0 | 0.5 |
DSO |
71.7 | 157.7 | 24.1 | 31.0 | 27.9 | 23.2 | 45.4 | - | - | - | - | - |
DIO |
48.9 | 93.9 | 76.4 | 48.6 | 122.2 | 89.8 | 70.8 | - | - | - | - | - |
DPO |
344.8 | 192.4 | 85.6 | 100.6 | 155.4 | 143.6 | 161.7 | - | - | - | - | - |
Operating Cycle |
120.6 | 251.6 | 100.5 | 79.6 | 150.1 | 112.9 | 116.3 | - | - | - | - | - |
Cash Conversion Cycle |
-224.2 | 59.1 | 14.9 | -21.0 | -5.3 | -30.7 | -45.5 | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Adamis Pharmaceuticals Corporation
| 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.2 | -0.06 | - | -2.05 | -0.06 | -0.07 | - | -0.08 | -0.06 | -0.12 | - | -0.15 | -0.18 | -0.11 | - | -0.12 | -0.16 | -0.19 | - | -0.21 | -0.29 | -0.23 | - | -0.21 | -0.19 | -0.26 | - | -0.41 | -0.37 | -0.48 | - | -0.23 | -0.27 | -0.24 | - | -0.2 | -0.27 | -0.15 | -0.82 | - | -0.17 | - | -0.34 | -0.96 | -0.04 | - | -0.01 | -0.04 | -0.03 | - |
EBITDA per Share |
-0.45 | -0.04 | - | -1.97 | -0.05 | -0.05 | - | -0.07 | -0.05 | -0.05 | - | -0.06 | -0.14 | -0.14 | - | -0.11 | -0.15 | -0.17 | - | -0.16 | -0.24 | -0.2 | - | -0.11 | -0.13 | -0.22 | - | -0.25 | -0.47 | -0.43 | - | -0.19 | -0.23 | -0.3 | - | -0.1 | -0.23 | -0.17 | -0.15 | -0.16 | -0.28 | - | -0.13 | -0.4 | -0.02 | - | -0.01 | -0.04 | -0.03 | - |
ROE % |
-190.61 | -336.06 | -338.96 | -374.82 | -256.08 | -156.79 | -83.68 | -408.51 | -697.48 | -1047.07 | -901.56 | -920.98 | -615.57 | -267.50 | -65.55 | -84.56 | -84.14 | -83.46 | -56.10 | -73.22 | -71.33 | -63.12 | -44.28 | -70.57 | -79.73 | -89.77 | -74.24 | -108.04 | -115.56 | -132.08 | -106.67 | -129.02 | -117.58 | -108.76 | -69.01 | -123.76 | -100.76 | -48.85 | 28.34 | 143.95 | 252.91 | 254.78 | 298.75 | 281.86 | 355.90 | 449.40 | 43.96 | 183.65 | 221.79 | - |
ROA % |
-186.51 | -218.48 | -117.59 | -145.02 | -136.20 | -103.36 | -61.11 | -97.92 | -107.30 | -134.55 | -102.15 | -116.79 | -94.61 | -68.91 | -49.38 | -64.59 | -65.16 | -65.62 | -44.89 | -58.06 | -56.02 | -49.06 | -34.07 | -51.65 | -56.07 | -61.52 | -49.67 | -75.77 | -84.28 | -99.38 | -82.37 | -98.84 | -89.21 | -81.33 | -50.85 | -88.30 | -72.73 | -50.39 | -252.73 | -429.66 | -1156.21 | -1141.19 | -1539.68 | -1723.80 | -1995.76 | -1793.23 | -398.49 | -999.42 | -395.32 | - |
ROCE % |
-197.24 | -375.00 | -328.52 | -358.17 | -225.17 | -125.46 | -57.31 | -214.63 | -342.31 | -647.47 | -772.17 | -791.62 | -653.74 | -353.69 | -65.75 | -84.83 | -84.47 | -83.68 | -56.09 | -70.75 | -66.32 | -58.04 | -41.53 | -67.54 | -78.89 | -95.85 | -79.21 | -114.72 | -124.22 | -132.74 | -117.97 | -138.40 | -123.32 | -114.35 | -67.41 | -77.16 | -37.33 | 25.72 | 66.81 | 99.61 | 126.04 | 105.96 | 149.80 | 170.60 | 307.07 | 445.91 | 43.85 | 182.30 | 219.77 | - |
Current Ratio |
0.6 | 0.5 | 0.9 | 1.3 | 1.7 | 2.1 | 3.1 | 4.2 | 3.7 | 3.2 | 1.1 | 1.1 | 1.1 | 1.1 | 3.2 | 4.0 | 4.0 | 4.0 | 5.0 | 5.0 | 5.0 | 5.0 | 4.3 | 4.3 | 4.3 | 4.3 | 3.0 | 3.0 | 3.0 | 3.0 | 4.4 | 4.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | 39.6 | 1736.0 | 92.2 | - | 122.8 | 89.5 | 47.0 | - | 70.2 | 25.4 | 29.1 | - | 29.0 | 29.7 | 28.2 | - | 27.5 | 26.9 | 28.5 | - | 22.4 | 19.9 | 24.6 | - | 35.4 | 38.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
178.9 | 48.6 | - | 42.4 | 31.3 | 14.1 | - | 63.2 | 120.1 | 93.6 | - | 140.1 | 60.7 | 64.1 | - | 47.1 | 51.3 | 67.2 | - | 130.1 | 125.0 | 112.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
2662.7 | 452.1 | - | 271.8 | 622.8 | 269.5 | - | 159.2 | 179.0 | 143.8 | - | 170.1 | 68.0 | 96.0 | - | 97.6 | 106.2 | 106.2 | - | 165.4 | 158.9 | 156.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
178.9 | 48.6 | - | 82.0 | 1767.3 | 106.2 | - | 186.0 | 209.6 | 140.6 | - | 210.3 | 86.1 | 93.1 | - | 76.2 | 81.0 | 95.4 | - | 157.6 | 151.8 | 141.3 | - | 22.4 | 19.9 | 24.6 | - | 35.4 | 38.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-2483.8 | -403.6 | - | -189.8 | 1144.4 | -163.3 | - | 26.8 | 30.6 | -3.2 | - | 40.2 | 18.1 | -2.9 | - | -21.4 | -25.2 | -10.8 | - | -7.9 | -7.1 | -15.4 | - | 22.4 | 19.9 | 24.6 | - | 35.4 | 38.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency